本期内容提示:
1、一大波核心仓位出现建仓机会,优先考虑哪些?
2、又一只有翻倍潜力的成长股临近理想建仓区;
3、$Rxi Pharmaceuticals Corp(PHIO)$ 数据不错,可否追涨?
$恒瑞医药(SH600276)$ $华东医药(SZ000963)$查看全文
Replix锐璞美股2021-03-01 21:16
$Phio Pharmaceuticals(PHIO)$ PHIO PHARMACEUTICALS AND AGONOX, INC. ANNOUNCE COLLABORATION ON CLINICAL DEVELOPMENT OF NOVEL T CELL-BASED CANCER IMMUNOTHERAPIES
Under the terms of the collaboration agreement, AgonOx will receive financial support for the clinical trial from...查看全文
Replix锐璞美股2021-02-18 14:08
$Phio Pharmaceuticals(PHIO)$ 公司增发完毕,看看是否能翻身。
$基因进化ETF-ARK(ARKG)$ $富途控股(FUTU)$查看全文
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, item 5.07 Accession Number: 0001683168-20-000082 Act: 34 Size: 18 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, item 8.01 Accession Number: 0001683168-19-004008 Act: 34 Size: 20 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001683168-19-003967 Act: 34 Size: 31 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001683168-19-003961 Act: 34 Size: 34 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K/A [Amend] Current report, items 3.01 and 9.01 Accession Number: 0001683168-19-003908 Act: 34 Size: 40 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-19-003804 Act: 34 Size: 335 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-057511 Size: 4 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-057518 Size: 4 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-057506 Size: 4 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-057497 Size: 5 KB 网页链接